← Open Payments lookup

BROOKE HOLDEN: Open Payments

NPI 1598205320 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$964 in 32 payments from 11 companies in 2025. Trend: 2023 $1,974 · 2024 $1,478 · 2025 $964

Food & beverage: $866Education: $98
CompanyPaymentsAmount
Janssen Biotech, Inc.7$233
Gilead Sciences, Inc.10$213
Lilly USA, LLC5$175
SANOFI-AVENTIS U.S. LLC1$121
Janssen Scientific Affairs, LLC1$63
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$38
Dexcom, Inc.1$36
Takeda Pharmaceuticals U.S.A., Inc.2$31
Aimmune Therapeutics, Inc.1$21
Regeneron Healthcare Solutions, Inc.1$18

Products named: TREMFYA, ZEPBOUND, TZIELD, OMVOH, XIFAXAN, Dexcom G6 Transmitter, EOHILIA, ZENPEP.

Industry payments across NY — which companies pay providers there.